Diampa-M Tablets

Diampa-M – Comprehensive Glycemic Control for Type 2 Diabetes

Diampa-M is a powerful combination anti-diabetic medication that unites Empagliflozin and Metformin HCl in a single oral tablet. This formula is specifically indicated for the treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise. It is a primary therapeutic choice for patients who are insufficiently controlled on their maximally tolerated dose of metformin alone. By combining two agents with different mechanisms of action, Diampa-M targets the disease through multiple biological pathways simultaneously.

The Metformin component improves the body's sensitivity to its own insulin and reduces the amount of glucose produced by the liver. The Empagliflozin component, an SGLT2 inhibitor, helps the kidneys remove excess sugar from the bloodstream and excrete it through the urine. This dual mechanism provides steady control of blood sugar levels throughout the day and night. Diampa-M is also used in combination with other diabetes treatments for patients with more advanced metabolic needs. Taking the medication with meals helps optimize its effectiveness and ensures patient comfort by reducing potential stomach upset.

• Indicated for type 2 diabetes as an adjunct to diet and exercise.
• Combines glucose-excreting and insulin-sensitizing actions.
• Provides cardiovascular and renal protective benefits.
• Available as: Film Coated Tablets in multiple strengths (5/500mg to 12.5/1000mg).